|
|
||||||||










,
* Bonfils Blood Center and
Department of Pediatrics and
Surgery, University of Colorado Denver School of Medicine, and
Department of Pathology, Childrens Hospital, Denver, CO 80230
Neutrophils (polymorphonuclear leukocytes, PMNs) are vital to innate immunity and receive proinflammatory signals that activate G protein-coupled receptors (GPCRs). Because GPCRs transduce signals through clathrin-mediated endocytosis (CME), we hypothesized that platelet-activating factor (PAF), an effective chemoattractant that primes the PMN oxidase, would signal through CME, specifically via dynamin-2 activation and endosomal formation resulting in membrane translocation of cytosolic phagocyte oxidase (phox) proteins. PMNs were incubated with buffer or 2 µM PAF for 1–3 min, and in some cases activated with PMA, and O2– was measured, whole-cell lysates and subcellular fractions were prepared, or the PMNs were fixed onto slides for digital or electron microscopy. PAF caused activation of dynamin-2, resulting in endosomal formation that required PI3K and contained early endosomal Ag-1 (EEA-1) and Rab5a. The apoptosis signal-regulating kinase-1/MAPK kinase-3/p38 MAPK signalosome assembled on Rab5a and phosphorylated EEA-1 and Rab GDP dissociation inhibitor, with the latter causing Rab5a activation. Electron microscopy demonstrated that PAF caused two distinct sites for activation of p38 MAPK. EEA-1 provided a scaffold for recruitment of the p40phox-p67phox complex and PI3K-dependent Akt1 phosphorylation of these two phox proteins. PAF induced membrane translocation of p40phox-p67phox localizing to gp91phox, which was PI3K-, but not p47phox-, dependent. In conclusion, PAF transduces signals through CME, and such GPCR signaling may allow for pharmacological manipulation of these cells to decrease PMN-mediated acute organ injury.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by Grants HL59355 and GM49222 from the National Heart, Lung, and Blood Institute and National Institute of General Medical Sciences, National Institutes of Health, and Bonfils Blood Center.
2 Address correspondence and reprint requests to Dr. Christopher C. Silliman, Bonfils Blood Center, 717 Yosemite Street, Denver, CO 80230. E-mail address: christopher.silliman{at}uchsc.edu
3 Abbreviations used in this paper: CME, clathrin-mediated endocytosis; GPCR, G protein-coupled receptors; CCV, clathrin-coated vesicle; SNARE, soluble NSF attachment protein receptor; PMN, polymorphonuclear leukocyte; EEA-1, early endosome Ag-1; PAF, platelet-activating factor; PAFR, platelet-activating factor receptor; p67phox, 67-kDa phagocyte oxidase protein; p40phox, 40-kDa phagocyte oxidase protein; MKK3, mitogen-activated kinase kinase 3; RabGDI, Rab GDP dissociation inhibitor; PS, phosphoserine; PY, phosphotyrosine; FRET, fluorescent resonance energy transfer; FRETC, FRET channel; a.l.u.f.i., arbitrary linear units of fluorescent intensity; PIP3, phosphatidylinositol 3,4,5-triphosphate; PIP2, phosphatidylinositol 4,5-diphosphate.
This article has been cited by other articles:
![]() |
P. C. Eckels, A. Banerjee, E. E. Moore, N. J. D. McLaughlin, L. M. Gries, M. R. Kelher, K. M. England, F. Gamboni-Robertson, S. Y. Khan, and C. C. Silliman Amantadine inhibits platelet-activating factor induced clathrin-mediated endocytosis in human neutrophils Am J Physiol Cell Physiol, October 1, 2009; 297(4): C886 - C897. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |